SMTL ID : 6es0.2 (1 other biounit)

Crystal structure of the kinase domain of human RIPK2 in complex with the activation loop targeting inhibitor CS-R35

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.38 Å

Oligo State

monomer

Ligands

1 x BW8: 2-[2-fluoranyl-4-[[2-fluoranyl-4-[2-(methylcarbamoyl)pyridin-4-yl]oxy-phenyl]carbamoylamino]phenyl]sulfanylethanoic acid(Non-covalent)

BW8.1: 25 residues within 4Å: Chain A: L.24, R.26, V.32, A.45, K.47, E.66, I.69, L.70, L.79, I.93, T.95, E.96, Y.97, M.98, G.101, L.142, L.143, H.144, L.153, I.162, A.163, D.164, F.165, K.169, W.170 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:K.47, A:I.69, A:L.70, A:L.79, A:L.153, A:D.164, A:F.165, A:W.170 Hydrogen bonds: A:E.66, A:E.66, A:M.98, A:M.98, A:D.164 Salt bridges: A:H.144, A:K.169

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Suebsuwong, C. et al., Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors. Bioorg. Med. Chem. Lett. (2018)

Release Date

2018-02-21

Peptides

Receptor-interacting serine/threonine-protein kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Receptor-interacting serine/threonine-protein kinase 2

Related Entries With Identical Sequence